That's not Metastatic Thyroid Cancer: Patterns of Non-malignant Radioiodine Uptake
<p>Radioactive Iodine (RAI) has been an integral part of the identification, surveillance, and treatment of the most common types of metastatic thyroid carcinoma since its first use in 1941. However, false positive uptake of RAI on whole body scintigraphy scans in tissues other than in metasta...
Saved in:
Main Author: | Daniella F Pinho (Author) |
---|---|
Format: | Book |
Published: |
Imaging Journal of Clinical and Medical Sciences - Peertechz Publications,
2017-06-19.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
APOPTOSIS ROLE IN FORMING RADIOIODINE RESISTANCE IN DIFFERENTIATED THYROID CANCER
by: K.A. GARIPOV, et al.
Published: (2020) -
Pharmacoeconomic effectiveness of lenvatinib in patients with differentiated radioiodine-resistant thyroid cancer
by: S. K. Zyryanov, et al.
Published: (2018) -
mutations and aggressive histopathologic characteristics of radioiodine-refractory papillary thyroid cancer
by: Ju Yeon Pyo, et al.
Published: (2024) -
Cost-Effectiveness of Apatinib and Cabozantinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
by: Bo Shi, et al.
Published: (2022) -
In Silico Screening and Validation of PDGFRA Inhibitors Enhancing Radioiodine Sensitivity in Thyroid Cancer
by: Xuefei Yu, et al.
Published: (2022)